These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9055182)

  • 1. Stability behaviour of molsidomine-containing pellet formulations.
    Laicher A; Jünger H; Klemm FH
    J Pharm Pharmacol; 1997 Feb; 49(2):131-4. PubMed ID: 9055182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particular features of photolabile substances in tablets.
    Aman W; Thoma K
    Pharmazie; 2003 Sep; 58(9):645-50. PubMed ID: 14531462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of formulation and manufacturing process on the photostability of tablets.
    Aman W; Thoma K
    Int J Pharm; 2002 Aug; 243(1-2):33-41. PubMed ID: 12176293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The physicochemical properties of molsidomine preparations and their efficacy in treating IHD and circulatory failure].
    Körner A; Ol'binskaia LI; Sizova ZhM; Morozov IuA
    Ter Arkh; 1995; 67(8):25-7. PubMed ID: 7482326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple-layer compression-coated tablets: formulation and humidity studies of novel chewable amoxicillin/clavulanate tablet formulations.
    Wardrop J; Jaber AB; Ayres JW
    Drug Dev Ind Pharm; 1998 Aug; 24(8):729-36. PubMed ID: 9876520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light stability of molsidomine in infusion fluids.
    Vandenbossche GM; De Muynck C; Colardyn F; Remon JP
    J Pharm Pharmacol; 1993 May; 45(5):486-8. PubMed ID: 8099974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of degradation of imidapril hydrochloride in finished dosage formulations.
    Stanisz B; Regulska K
    Acta Pol Pharm; 2013; 70(4):737-42. PubMed ID: 23923397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICH guideline for photostability testing: aspects and directions for use.
    Aman W; Thoma K;
    Pharmazie; 2003 Dec; 58(12):877-80. PubMed ID: 14703965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of multiple-unit pellet system tablets by employing the SeDeM expert diagram system II: pellets containing different active pharmaceutical ingredients.
    Hamman H; Hamman J; Wessels A; Scholtz J; Steenekamp J
    Pharm Dev Technol; 2019 Feb; 24(2):145-156. PubMed ID: 29394129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UV imaging of multiple unit pellet system (MUPS) tablets: A case study of acetylsalicylic acid stability.
    Novikova A; Carstensen JM; Rades T; Leopold CS
    Eur J Pharm Biopharm; 2017 Oct; 119():447-453. PubMed ID: 28780276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability Studies of a Freeze-Dried Recombinant Human Epidermal Growth Factor Formulation for Wound Healing.
    Santana H; García G; Vega M; Beldarraín A; Páez R
    PDA J Pharm Sci Technol; 2015; 69(3):399-416. PubMed ID: 26048746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug formulations intended for the global market should be tested for stability under tropical climatic conditions.
    Risha PG; Vervaet C; Vergote G; Bortel LV; Remon JP
    Eur J Clin Pharmacol; 2003 Jun; 59(2):135-41. PubMed ID: 12721773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.
    Aryal S; Skalko-Basnet N
    Acta Pharm; 2008 Sep; 58(3):299-308. PubMed ID: 19103566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery.
    Zhang Y; Wang R; Wu J; Shen Q
    Int J Pharm; 2012 May; 427(2):337-44. PubMed ID: 22366381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
    Messin R; Opolski G; Fenyvesi T; Carreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
    Int J Cardiol; 2005 Jan; 98(1):79-89. PubMed ID: 15676171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling the chemical stability of a moisture-sensitive drug product through monitoring and identification of coating process microenvironment.
    Kestur U; Pandey P; Badawy S; Lin J; Desai D
    Int J Pharm; 2014 Dec; 476(1-2):93-8. PubMed ID: 25261712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability studies of anticancer agent bis(4-fluorobenzyl)trisulfide and synthesis of related substances.
    Bao Y; Mo X; Xu X; He Y; Xu X; An H
    J Pharm Biomed Anal; 2008 Nov; 48(3):664-71. PubMed ID: 18678459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fingerprint analysis and multi-ingredient quantitative analysis for quality evaluation of Xiaoyanlidan tablets by ultra high performance liquid chromatography with diode array detection.
    Tang DQ; Li Z; Jiang XL; Li YJ; Du Q; Yang DZ
    J Sep Sci; 2014 Aug; 37(16):2131-7. PubMed ID: 24890779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of cyanocobalamin in sugar-coated tablets.
    Ohmori S; Kataoka M; Koyama H
    Int J Pharm; 2007 Jun; 337(1-2):161-8. PubMed ID: 17300886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.